Scientific Sessions 2025  /  HFpEF in 2025: Trials and Triumphs  /  Exploring the Interplay Between Afib and HFpEF
Logo

American Heart Association

  33
  0

Final ID:

Exploring the Interplay Between Afib and HFpEF

  • Zakeri, Rosita  ( King's College London , London , United Kingdom )
  • Gersh, Bernard  ( Mayo Clinic , Rochester , Minnesota , United States )
  • Tumolo, Alexis  ( University of Colorado Hospital , Aurora , Colorado , United States )
    • Author Disclosures:
    Rosita Zakeri: DO have relevant financial relationships ; Consultant:AstraZeneca:Past (completed) ; Other (please indicate in the box next to the company name):SERB Pharmaceuticals, publication fees:Past (completed) ; Speaker:Johnson & Johnson:Past (completed) ; Consultant:Boehringer Ingelheim:Past (completed) | Bernard Gersh: DO NOT have relevant financial relationships | Alexis Tumolo: DO have relevant financial relationships ; Speaker:Boston Scientific:Active (exists now) ; Other (please indicate in the box next to the company name):Abbott, Education:Active (exists now) ; Speaker:Biosense Webster:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

HFpEF in 2025: Trials and Triumphs

Monday, 11/10/2025 , 01:30PM - 02:45PM

Main Event

More abstracts on this topic:
The Future of HFpEF Treatment: Novel Pillars of Medical Therapy

Sweitzer Nancy, Solomon Scott, Mcdonagh Theresa

The Changing Landscape of HF: HFpEF as The Predominant Form of HF

Ho Jennifer, Pandey Ambarish

More abstracts from these authors:
Long QT Syndrome: What's the Long and Short of It?

Aziz Peter, Tzou Wendy, Ackerman Michael, Tumolo Alexis

Current and future management of AF in HF

Zakeri Rosita, Ellinor Patrick

You have to be authorized to contact abstract author. Please, Login
Not Available